Vaxart shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $4 price target.
Portfolio Pulse from Benzinga Newsdesk
Vaxart shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $4 price target.
August 15, 2024 | 3:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vaxart shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $4 price target.
The initiation of coverage by a reputable firm like Oppenheimer with an Outperform rating and a specific price target of $4 is likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100